Shilpa Medicare Limited

NSEI:SHILPAMED 주식 보고서

시가총액: ₹77.5b

Shilpa Medicare 과거 수익 실적

과거 기준 확인 2/6

Shilpa Medicare의 수입은 연평균 -47.2%의 비율로 감소해 온 반면, Pharmaceuticals 산업은 수입이 연평균 13.4%의 비율로 증가했습니다. 매출은 연평균 6.5%의 비율로 증가해 왔습니다. Shilpa Medicare의 자기자본이익률은 2.6%이고 순이익률은 5%입니다.

주요 정보

-47.2%

수익 성장률

-48.5%

EPS 성장률

Pharmaceuticals 산업 성장17.5%
매출 성장률6.5%
자기자본 수익률2.6%
순이익5.0%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Recent updates

What Shilpa Medicare Limited's (NSE:SHILPAMED) 28% Share Price Gain Is Not Telling You

Sep 12
What Shilpa Medicare Limited's (NSE:SHILPAMED) 28% Share Price Gain Is Not Telling You

Shilpa Medicare Limited's (NSE:SHILPAMED) 29% Price Boost Is Out Of Tune With Revenues

Jul 05
Shilpa Medicare Limited's (NSE:SHILPAMED) 29% Price Boost Is Out Of Tune With Revenues

What Shilpa Medicare Limited's (NSE:SHILPAMED) 27% Share Price Gain Is Not Telling You

Apr 12
What Shilpa Medicare Limited's (NSE:SHILPAMED) 27% Share Price Gain Is Not Telling You

Shilpa Medicare Limited's (NSE:SHILPAMED) Shares Climb 28% But Its Business Is Yet to Catch Up

Feb 21
Shilpa Medicare Limited's (NSE:SHILPAMED) Shares Climb 28% But Its Business Is Yet to Catch Up

Shilpa Medicare (NSE:SHILPAMED) Takes On Some Risk With Its Use Of Debt

Jan 02
Shilpa Medicare (NSE:SHILPAMED) Takes On Some Risk With Its Use Of Debt

These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Extensively

Jul 17
These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Extensively

Shilpa Medicare (NSE:SHILPAMED) Seems To Be Using A Lot Of Debt

Mar 17
Shilpa Medicare (NSE:SHILPAMED) Seems To Be Using A Lot Of Debt

Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)

Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)

Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Sep 07
Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Aug 14
Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Here's Why Shilpa Medicare (NSE:SHILPAMED) Is Weighed Down By Its Debt Load

Jan 27
Here's Why Shilpa Medicare (NSE:SHILPAMED) Is Weighed Down By Its Debt Load

Shareholders May Not Be So Generous With Shilpa Medicare Limited's (NSE:SHILPAMED) CEO Compensation And Here's Why

Sep 21
Shareholders May Not Be So Generous With Shilpa Medicare Limited's (NSE:SHILPAMED) CEO Compensation And Here's Why

Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

Jun 17
Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

If You Like EPS Growth Then Check Out Shilpa Medicare (NSE:SHILPAMED) Before It's Too Late

May 31
If You Like EPS Growth Then Check Out Shilpa Medicare (NSE:SHILPAMED) Before It's Too Late

Shilpa Medicare Limited's (NSE:SHILPAMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Mar 07
Shilpa Medicare Limited's (NSE:SHILPAMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Shilpa Medicare Limited (NSE:SHILPAMED) Analysts Are Reducing Their Forecasts For Next Year

Feb 20
Shilpa Medicare Limited (NSE:SHILPAMED) Analysts Are Reducing Their Forecasts For Next Year

Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

Jan 26
Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

수익 및 비용 분석

Shilpa Medicare 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

NSEI:SHILPAMED 수익, 비용 및 수입 (INR Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 2412,1636113,0480
30 Jun 2411,8394482,8080
31 Mar 2411,5313193,0250
31 Dec 2311,248-72,9780
30 Sep 2311,008-1192,9730
30 Jun 2310,491-3212,8730
31 Mar 2310,517-3252,9690
31 Dec 2211,286513,0630
30 Sep 2211,3842133,0540
30 Jun 2211,6935992,7950
31 Mar 2211,4696072,8240
31 Dec 2110,1353952,6920
30 Sep 219,3243762,6120
30 Jun 219,1566312,4040
31 Mar 219,0161,4782,4730
31 Dec 209,1351,7392,2810
30 Sep 209,5912,2132,1680
30 Jun 209,6982,2672,0270
31 Mar 209,0821,5622,0430
31 Dec 198,8761,4552,0220
30 Sep 198,2411,0291,9830
30 Jun 196,9629441,8260
31 Mar 197,3371,1231,8340
31 Dec 187,6931,1931,7760
30 Sep 187,8141,2811,7040
30 Jun 188,2111,1671,5660
31 Mar 187,8941,0521,5550
31 Dec 177,7561,1331,4980
30 Sep 177,7311,1491,4220
30 Jun 177,7871,1901,3190
31 Mar 177,7951,0761,3300
31 Dec 167,5651,0481,1580
30 Sep 167,7351,1531,0920
30 Jun 167,3691,0241,0070
31 Mar 167,1661,0839340
31 Dec 156,8678861,170159
30 Sep 156,4307761,113159
30 Jun 156,2347288440
31 Mar 156,1387378550
31 Dec 146,14573199795
30 Sep 146,14379899195
30 Jun 145,9667877230
31 Mar 145,71475791395
31 Dec 135,02566476746

양질의 수익: SHILPAMED 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: SHILPAMED 는) 과거에 수익을 냈습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: SHILPAMED 의 수입은 지난 5년 동안 매년 47.2% 씩 감소했습니다.

성장 가속화: SHILPAMED 지난해 흑자를 기록해 5년 평균과 비교하기 어려운 수익 성장률을 보이고 있습니다.

수익 대 산업: SHILPAMED 작년에 수익을 올렸기 때문에 지난 해 수익 성장을 Pharmaceuticals 업계( 20% )와 비교하기가 어렵습니다.

자기자본 수익률

높은 ROE: SHILPAMED 의 자본 수익률( 2.6% )은 낮음으로 간주됩니다.

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기

7D

1Y

7D

1Y

7D

1Y